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Abstract
The specific DNA is typically impermeable to the plasma membrane due to its natural characters, but DNA tetra
structures (DTNs) can be readily uptake by cells in the absence of transfection agents, providing a new strategy to
deliver DNA drugs. In this research, the delivery efficiency of tetrahedral DNA nanostructures was measured on
adenocarcinomic human alveolar basal epithelial (A549) cells via delivering AS1411 (G4). The DNA tetra-AS1411
complex was rapidly and abundantly uptake by A549 cells, and the induced apoptosis was enhanced. Furthermore,
biodistribution in mouse proved the rapid clearance from non-targeted organs in vivo. This study improved the
understanding of potential function in DNA-based drug delivery and proved that DTNs-AS1411 could be potentially
useful for the treatment of lung cancer.
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Background
Lung cancer is the leading cancer-related death cause in
the world [1]. Despite therapeutic advances, the account-
ing is increased every year. Medicine therapy is an im-
portant scheme in lung cancer treatment due to the
complexity in lesions [2, 3]. By now, though traditional
therapy and some new-developed therapy of lung cancer
have been eutherapeutic, effective drug delivery is still
absent.
A special molecular DNA, G-quadruplex (also known
as G4 structure), is formed in nucleic acids, and the se-
quences are rich in guanine [4, 5]. The guanine tetrad is
formed through Hoogsteen hydrogen bonding by every
four guanine, and two or more guanine tetrads can stack
on top of each other to form a completed G-quadruplex
[6, 7]. AS1411 is a G-rich quadruplex oligodeoxynucleo-
tide that binds specifically to nucleolin and has been
proved as an active oligo-drug for tumor therapy.
AS1411 has been used as an anti-tumor drug or tumor-
targeting agent [8–11]. The previous studies has proved
that AS1411 can be taken up in cancer cells by macropi-
nocytosis (fluid phase endocytosis) and distributed in the
cells subsequently [12, 13]. As a high effective aptamer,
AS1411 can recognize and bind nucleolin, the target
protein in both cytomembrane and nucleus [14]. Mean-
while, the expression of nucleolin, which induces tumor
cells anti-apoptosis, is usually higher in tumor cells [15,
16]. Hence, AS1411 is considered a precise inhibitor for
nucleolin and relative signal pathway. The therapeutic
effect in phase I clinical trials of patients is obvious, indi-
cating that AS1411 is well tolerated with much of cancer
treatment. In further studies, AS1411 was proved as a
significant apoptotic inducer in adenocarcinomic human
alveolar basal epithelial (A549) cells even lung tumor tis-
sues [17]. However, the intracellular delivery of naked
AS1411 is hardly possible due to naked oligodeoxynu-
cleotides are not through the cell membrane directly in
common serum.
Nano-drug delivery system, especially DNA nano-
structure-based carrier, has already been a promising
approach to assist AS1411 into target cells. The emer-
gence of nano-biotechnology has provided widely op-
portunities for exogenous naked nucleic acid delivery in
target cells [18]. DNA nanostructures have been
employed as an efficiency drug carrier into cells because
of their suitable sizes, structures, and synthesis. In pre-
vious studies, immunostimulatory CpG oligonucleotides
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are delivered into target cells as a significant immune-
stimulating drug by DNA tetrahedra structures (DTNs)
[19, 20], a 3D molecular cage formed with four DNA
chains according to the principle of Watson-Crick base
pairing [21]. Compared with naked DNA, DTN-
compacted nanostructures offer greater flexibility in de-
sign and functionality and probably higher stability in
cells. This discovery advocates new opportunities for
DNA-based bio-interaction and smart drug delivery into
live cells.
Normally, cellular uptake of DNA typically relies on
positively charged transfection agents, which are special
agents together with the DNA. DNAs are allowed to
traverse the negatively charged cellular membrane by
this strategy. Interestingly, some DNA artificial nano-
structures (such as DTNs) can be internalized by mam-
malian cells without the aid of transfection agents. In
this study, we design a new complex of DTNs and
AS1411 (Fig. 1), which is defined as the functional drug
with the delivery cargo of DTNs by self-assemble tech-
nology. We herein explore the whole process of DTNs-
AS1411 intracellular delivery and the apoptosis-inducing
effects on the A549 cells. Furthermore, the metabolic
pathway of DTNs-AS1411 in mouse is examined via
SPECT/CT technology.
Methods
Chemicals and Materials
Phosphate-buffered saline (PBS, pH = 7.4) was purchased
from Sangon Co, Ltd (China), 3-(4,5-dimethyl-2-thiazolyl)-
2, 5-diphenyl-2-H-tetrazolium bromide (MTT), sodium
dodecyl sulfate (SDS), polyacrylamide, bis-acrylamide, and
TARMA were purchased from Sigma-Aldrich Co, Ltd
(USA). Dulbecco’s modified Eagle’s medium (DMEM),
fetal bovine serum (FBS), and penicillin-streptomycin
solution were purchased from Invitrogen. Other chemicals
were purchased from Sigma-Aldrich Co, Ltd. Anti-Bcl-2,
anti-Bax, and anti-Caspase-3 proteins were purchased
from Abcam Co. Ltd (Great Britain).
Synthesis, Quantification, and Characterization of DNA
Sequence
All DNA sequences were synthesized and purchased
from TAKARA Co, Ltd (Japan). The oligonucleotides
were used as AS1411: 5′-d (GGTGGTGGTGGTTGTG
GTGGTGGTGG)-3′, and an inactive control oligonucleo-
tide: 5′-dTTT (CCTCCTCCTCCTTCTCCTCCTCCTC
C)-3′. The extra-TTT nucleotides in control oligonucleo-
tides are the conjunction site with DTNs. The sequences
of DTNs were as below:
A:
5′-ACATTCCTAAGTCTGAAACATTACAGCTTGC
TACACGAGAAGAGCCGCCATAGTA-(AAA)-3′
B:
5′-TTCAGACTTAGGAATGTGCTTCCCACGTAGT
GTCGTTTGTATTGGACCCTCGCAT-(AAA)-3′
C:
5′-TCAACTGCCTGGTGATAAAACGACACTACGT
GGGAATCTACTATGGCGGCTCTTC-(AAA)-3′
D:
5′-TATCACCAGGCAGTTGACAGTGTAGCAAGCT
GTAATAGATGCGAGGGTCCAATAC-(AAA)-3′
The sequence—(AAA)—is the bonding site with AS1411
in every chain if necessary.
Fig. 1 The mechanism of DTNs-AS1411 delivery system. AS1411 is linked with DTNs and then transported into A549 cells by DTNs. The main
target site of AS1411 is in nucleus
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The concentration of nucleic acids in solution can be
readily calculated from the absorbance at 260 nm (A260)
by UV spectrophotometry (Shimadzu Co, Ltd, Japan). One
microliter of every sample was diluted with 499 μL double-
distilled water and then examined for the relevant absorb-
ance. The formula of calculating DNA concentration is as:
concentration in μg/mL =A260 ×weight/optical density
(OD) × dilution factor. The dilution factor is defined by
1000/amount of suspended oligo added for the dilution.
For the synthesis of DTNs, every quantity DNA se-
quence was added into a reaction tube with the ratio 1:1.
Then, the reaction system was heated to 95 °C for 2 min
and then cooled to 4 °C for 30 s by PCR (Bio-Rad Co,
Ltd., USA). All synthesized DNA structures were ana-
lyzed with agarose gel electrophoresis (1.2 %).
For the synthesis of AS1411, every quantity DNA
sequence was added into a reaction tube at room
temperature for 1 h. Then, the production is analyzed
with agarose gel electrophoresis (1.2 %).
For the synthesis of DTNs-AS1411, the extra-TTT
nucleotide chain of DTNs and AS1411 were the special
sequences for synthesis. The reactions were heated to
95 °C for 2 min and then cooled to 4 °C for 30 s by PCR.
The amount of AS1411 in each complex was controlled
with the addition of nude AS1411 in the reaction sys-
tem. All synthesized DNA structures were analyzed with
agarose gel electrophoresis (1.2 %), and part of typical
products was measured by dynamic light scattering.
Cytotoxicity of DNA Structures
A549 cell lines were purchased from Cell Bank of Chinese
Academy of Sciences (Shanghai). Then cells were cultured
in DMEM medium with 10 % heat inactivated FBS, 0.15 %
NaHCO3, 100 units/mL penicillin, 100 mg/mL strepto-
mycin, and 2 mM L-glutamine at 37 °C in humidified air
containing 5 % CO2.
Cytotoxicity was estimated using MTT assay. Firstly,
cells were seeded in 96-well plates and cultured over-
night to reach 80 % abundance. Then, the medium were
removed and replaced with 100 μL fresh culture
medium. Fresh media containing AS1411, DTNs, or
DTNs-AS1411 at indicated concentrations were incu-
bated with cells for 24 h. 20 μL 5 mg/mL MTT reagent
solution was then added to each well, followed by 4 h in-
cubation at 37 °C. Next, cells were lysed with 10 % acid
SDS solution (pH = 2–3). After centrifugation, the ab-
sorbance of supernatant was measured at 570 nm by
Microreader (Shimadzu Co, Ltd, Japan).
Cellular Uptake of DNA Sequences
TAMRA is a stabled fluorescence with red emission
(emission 542 nm, excitation 568 nm) in cell staining,
which can be observed by confocal microscopy. In order
to study the effects of A549 cells uptake ability, naked
AS1411, DTNs, and DTNs-AS1411 at 100 nM were la-
beled with TAMRA (labeled in the 5′ of a chain of
DTNs, such as AS1411). A549 were seeded on glass cov-
erslips and incubated at 37 °C. After 24 h incubation,
cells were washed with PBS and exposed to fresh culture
medium containing different DNA sequences and then
washed by PBS. The coverslips were mounted on a glass
slide, and then the cells cultured on coverslips were
fixed in 4 % paraformaldehyde for half an hour. After
washing by PBS for several times, cells were then incu-
bated with blocking buffer (2 % BSA) for 15 min. A special
antibody (1:500) was then added and incubated overnight
at 4 °C. After being washed, fluorescence-labeled second-
ary antibody was incubated for 1 h. Coverslips were then
washed, and cells were observed using a laser confocal
microscope (Leica TCS SP8, Germany).
Cellular Apoptosis
In the present studies, DNTs were exploited as promis-
ing therapeutic agents due to their high solubility, design
flexibility, and bio-safety. To test our hypothesis on
apoptosis inducing, 3 × 105 A549 cells were pretreated
with 100 nM AS1411, DTNs, and DTNs-AS1411 inde-
pendently for 6 h. Cell viability was then determined
using MTT assays. Cellular apoptosis was characterized
via western blot and TUNEL staining. A549 cells were
plated and treated in six-well plates. After being treated
with different DNA sequences, cells were washed several
times with PBS, and harvested by SDS-loading sample
buffer, and then boiled. Protein samples were then ana-
lyzed by 12 % SDS-PAGE and blotted to 0.22-μm diam-
eter PVDF membranes. The samples were blocked for
30 min using 6 % BSA in PBST buffer (0.1 % Tween 20)
and then incubated overnight at 4 °C with antibodies
against Bcl-2, Bax, and active Caspase-3 (1:1000) inde-
pendently. After being washed, the samples were probed
with a goat anti-rabbit horseradish peroxidase-
conjugated antibody (1:8000) for 1 h. The samples were
then incubated with ECL plus and exposed to X-ray film.
For TUNEL staining, the treated cell samples were
treated with TUNEL staining kit following the instruc-
tions, and the corresponding samples were stained with
DAPI to observe the amount of A549 cells.
Biodistribution of DTNs-AS1411
Three Balb/C mice (8 weeks, 28.5 g in average) were
purchased from Slac Laboratory animal (China) and re-
cruited in this research. Animal care and all experimen-
tal procedures were performed under the approval of the
Animal Care Committee of Fudan University. SPECT/
CT imaging was operated in the Department of Nuclear
Medicine, Shanghai Cancer Center, Fudan University.
Preparation of 99mTc-labeled DTNs-AS1411: Briefly, the
mixtures of DTNs-AS1411 and NHS-MAG3 in HEPES
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buffer (pH = 8.0) were incubated at room temperature
for 2 h and then purified on a P4 column with 0.1 M
PBS as eluent. The peak fractions were collected and
quantitated by UV spectrophotometry. For radiolabeling,
18.5 MBq 99mTc-pertechnetate generator elute was
added into a mixed solution of 40 μL (10 μg) of MAG3-
DTNs-AS1411 in PBS, 15 μL tartrate buffer (pH = 8.5),
and 5 μg SnCl2·2H2O in 0.01 M HCl. The solution was
heated to 50 °C for 20 min. The 99mTc-labeled DTNs-
AS1411 was purified by size exclusion radio-HPLC.
Aiming for the preliminary evaluation of biodistribution
and in vivo metabolic mechanism, 99mTc-DTNs-AS1411
(18.5 MBq/mouse) was administered to Balb/C mice via
tail vein injection. At 3 h post injection, mice were
anesthetized via 2 % isoflurane inhalation and scanned via
NanoSPECT/CT (Bioscan, Washington, DC) for 20 min.
Statistics
In this experiment, all significances were determined
using Student’s t distribution (two-tailed; two-sample
equal variance). *** equals P < 0.001; ** equals P < 0.01; *
equals P < 0.05; ns means not significant.
Results and Discussion
Synthesis, Characterization, and Cytotoxicity of AS1411,
DTNs, and DTNs-AS1411
1.2 % agarose gel electrophoresis was used to test the
differences of molecular sizes among AS1411, DTNs,
Fig. 2 The characterization of AS1411, DTNs, and DTNs-AS1411. a The agarose gel electrophoresis of DNA nanostructures with details labeled on
the band. b Diameters of DTNs and DTNs modified with 4 AS1411
Fig. 3 The stability of DTNs-AS1411 and cytotoxicity of DTNs. a The stability of DTNs-AS1411 in FBS (before and after incubation). b The viability
of A549 cells with DTNs treatments at different concentrations. c The viability of A549 cells with DTN treatments at different time
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Fig. 4 Cellular uptake of A549 cells with different DNA structures (red resulted from TRAMA)
Fig. 5 The apoptosis induced by the DNA structures in A549 cells. a The viability of A549 cells after being treated at 100 nm for 6 h. b The
viability of A549 cells treated with different concentration of DTNs-AS1411. c The viability of A549 cells treated with different times of DTNs-AS1411.
d The expression of BCl-2, Bax, and active Caspase-3 after different treatments. e TUNEL staining and DAPI staining of A549 cells treated with different
drugs. **P value < 0.05, *P value < 0.1
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and DTNs-AS1411 due to that agarose gels are particu-
larly suitable for separating molecular DNA of size and
qualify range. The agarose gel electrophoresis (Fig. 2a)
showed that DTNs-4AS1411 (4 AS1411 contained) was
of the biggest molecular weight, and naked AS1411 (just
26 base pairs) was of the smallest molecular DNA size.
Based on the molecular sizes reflected from the agarose
gel electrophoresis, AS1411, DTNs, and DTNs-AS1411
formations were successfully synthesized. For the dynamic
diameters of typical structures (Fig. 2b), the particle sizes
corresponded to the molecule weight, and 8.2 ± 2.2 nm
and 18.4 ± 3.7 nm were the particle sizes for DTNs and
DTNs-4AS1411, respectively.
Due to the basic character of DNA sequence, AS1411,
DTNs, and DTNs-AS1411 can assemble automatically
by base pair complementary mechanism at suitable
temperature. The stability of DTNs-AS1411 measured
via gel electrophoresis proved the stable performance
against nuclease degradation in biological media, where
the band intensity of DNA nanostructure remained as
the same as before 4 h incubation (Fig. 3a).
For cytotoxicity, DTNs with different sequence and
size were modified and confirmed safe to cells in pre-
vious studies. Cell compatibility of DTNs with differ-
ent concentrations in A549 cells was measured via
MTT assays (Fig. 3b, c). At concentrations between 10
and 100 nM, no significant effect on the viability of
A549 cells was detected during the first 24 h, indicat-
ing that DTNs with 55 bp ssDNA are compatible to
A549 cells.
Cellular Uptake of DTN Structures
The location and distribution of these DNA structures
were examined in different times during the whole up-
take process (Fig. 4). Significantly, a bright signal can be
observed throughout A549 cells incubated with both
DTNs and DTNs-AS1411. In contrast, there was min-
imal fluorescence in A549 cells with 100 nM AS1411
treated, suggesting that the ability of delivery by AS1411
itself was rarely. So, the presence of DTNs was crucial
for efficient intracellular delivery. Besides, the fluores-
cence of DTNs obviously increased with the time. Both
DTNs and DTNs-AS1411 were significantly higher than
that of AS1411, indicating the high cellular uptake effi-
ciency of DTNs. Furthermore, due to that DTNs and
DTNs-AS1411 showed similar cellular uptake efficiency,
the presence of DTNs motifs and the variation of the
valence number had little influence on the efficiency of
cellular uptake.
Apoptosis Induced by Different DTNs in A549 Cells
There were no significant differences of viability between
DTN treatment and control in A549 cells at 100 nM
(Fig. 5a). The decrease of cellular viability induced by
naked AS1411 was significant, but a more significant de-
crease was induced by the DTNs-AS1411 treatment. In
Fig. 5b, c, the viabilities of A549 cells varied with the
concentration of DTNs-AS1411 and the time length of
co-incubation, indicating that AS1411 itself will not
induce cytotoxicity obviously without the delivery of
DTNs.
Fig. 6 The biodistribution of 99mTc-DTNs-AS1411 in Balb/C mice at 3 h post injection
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As an anti-apoptotic factor that expressed in normal
state, BCl-2 has the ability to inhibit a wide variety of
apoptotic signals. Reversely, Bax protein has the pro-
apoptotic effect. Hence, the cellular Bcl-2/Bax ratio has
been proposed as a key factor in the regulation of
apoptosis in previous studies. Videlicet, Bcl-2/Bax ratio,
makes cells resistant to apoptotic stage, while a low ratio
induces cell death. Furthermore, Caspase proteinases,
such as Caspase-3, make apoptotic signaling after aspar-
tate residues, forming an activated protein in the apop-
totic cell both by extrinsic and intrinsic pathways. For
the western blot assays (Fig. 5d), a similar tendency to
Fig. 5a was detected. The expression of BCl-2 decreased
obviously in AS1411 and DNTs-AS1411 group. At the
same time, the expression of Bax and active Caspase-3
increased. Yet, more significant changes were observed
in DTNs-AS1411 group, indicating that the apoptotic-
induction function of DTNs-AS1411 was more obvious.
In the TUNEL staining results (Fig. 5e), DTNs-AS1411
lead to more apoptosis as well. Although DTNs are not
the cytotoxicity factor, the delivery effect for AS1411
was proved. In addition, given that these nanostructures
were stable because of their pairing, it is possible to
carry AS1411 and other molecular guides into tumor
cells for therapy.
Biodistribution in Mouse
Though naked AS1411 was proved as the actively anti-
cancer in clinics, the in vivo metabolic process of DTNs-
AS1411 is not clear. Hence, the biodistribution of
DTNs-AS1411 was examined by SPECT/CT. After the
intravenous injection of 99mTc-DTNs-AS1411, no acute
biotoxicity was observed during the first day post injec-
tion. Based on the SPECT/CT results (Fig. 6) scanned at
3 h post injection, more than 80 % DTNs-AS1411 have
been expelled, indicating a rapid clearing rate in vivo,
which is helpful to enhance the target/background ratio.
For the normal mice, DTNs-AS1411 accumulated in
RES-rich organs, such as the liver, and was mainly ex-
pelled via the bladder. Kidney metabolism was proved
the major metabolic pattern of exogenous DNA struc-
tures in mice. This was a beneficial response to avoid
the potential toxicity in vivo; due to that, DNAs did not
obviously accumulate in non-target organs.
Conclusions
DTN was confirmed as an excellent intracellular carrier
for the transcellular transportation of AS1411, and DTNs-
AS1411 is a potential strategy for lung cancer therapy with
a low cost and high efficiency.
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